The comics span topics from gene editing to clinical trials and statistical manipulations. Many are ultimately about how truthfully research is communicated — to patients, to the public, even to other scientists.
While about two-thirds of respondents expressed support for using gene editing to treat diseases, only one-third favored using the technology for enhancement, such as creating “designer babies.”
The National Academy of Sciences and National Academy of Medicine issued a 258-page report Tuesday (Feb. 14) focused on human genome editing. It lays out principles and recommendations for the U.S. government and governments around the globe grappling with how to handle rapid advances in human genome-editing technology as it applies to human health and …
R. Alta Charo will use the opportunity to focus on her research and write a book offering unconventional takes on several areas of bioethics.
R. Alta Charo, a professor of law and longtime student of the regulation and ethics of biotechnology, was named co-chair of a study committee established Nov. 12 by the National Academies of Sciences, Engineering, and Medicine to look into the implications of a faster, easier and more precise method for “editing” genes.
A bill before the State Assembly aimed at banning the scientific use of fetal tissue would halt work that could alleviate or end the suffering of innumerable patients struggling with diseases from Alzheimer’s to viral infections, scientists from the University of Wisconsin–Madison, the Medical College of Wisconsin and Wisconsin’s biomedical community told state legislators at …
Bioethicist Jeffrey Kahn and veterinary pathologist Eric Sandgren will meet on the University of Wisconsin–Madison campus Thursday evening for a discussion of animal research ethics focusing on a particular program employing monkeys in the study of anxiety and depression. The event, which is free and open to the public, begins 7 p.m. Thursday in Room 1111 of the Genetics-Biotechnology Center Building, 425 Henry Mall.
The 12th annual International Bioethics Forum, “Creative Insight: Further Studies in Human Consciousness,” will be held April 25 and 26 on the Promega Corporation campus.
The Morgridge Institute for Research will launch its Ethics@Discovery program on Thursday, May 31, at 2 p.m. with “Campus Conversation: Biomedical Research and National Security—Learning from the H5N1 Influenza Story.”
Go Big Read, UW-Madison’s common reading program, is off to a vigorous start. Some 5,000 copies of “The Immortal Life of Henrietta Lacks,” by Rebecca Skloot, were given away in September at the Chancellor’s Convocation for New Students.
University of Wisconsin-Madison professor of law R. Alta Charo has accepted a position as senior adviser in the Office of the Commissioner at the Food and Drug Administration, effective Aug. 30.
Today, a “blood drive” is a cheerful community event, featuring cookies and chats with the neighbors in the high school gym. But a century ago, the first successful blood donations occurred when two people were sewn together by their blood vessels as blood flowed from the donor to the recipient.
If ever there was a gnarly ethical trail to blaze, it’s the one that wends through modern biomedical science.
The 2008 International Bioethics Forum, to be held April 17-18 at Promega Corporation’s BioPharmaceutical Technology Center (BTC) in Fitchburg, will delve into the science and controversies of evolution in the 21st Century.
Norman Fost, professor in the departments of pediatrics and medical history and bioethics, and director of the Program in Bioethics, particpiated recently in an Intelligence Squared U.S. debate as an advocate for the motion “Should We Accept Steroid Use in Sports?”
When University of Wisconsin-Madison researchers succeeded in reprogramming skin cells to behave like embryonic stem cells, they also began to redefine the political and ethical dynamics of the stem-cell debate, a leading bioethicist says.
The interface among molecular biology, medical applications, law, religion and ethics will be the focus of the sixth annual international Bioethics Forum, hosted by Promega Corp.’s BioPharmaceutical Technology Center Institute (BTCI) in Fitchburg.